Paper41552007
Effects of modified release hydrocortisone on restoration of early morning cortisol, quality of life, and fatigue in adrenal insufficiency (The CHAMPAIN study): a randomised, double-blind, double-dummy, cross-over study comparing Chronocort and Plenadren.
Prete A and 15 others. EClinicalMedicine, 2026. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Effects of modified release hydrocortisone on restoration of early morning cortisol, quality of life, and fatigue in adrenal insufficiency (The CHAMPAIN study): a randomised, double-blind, double-dummy, cross-over study comparing Chronocort and Plenadren. Papers, record 41552007. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41552007
- Disease
- adrenocortical insufficiency11 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Effects of modified release hydrocortisone on restoration of early morning cortisol, quality of life, and fatigue in adrenal insufficiency (The CHAMPAIN study): a randomised, double-blind, double-dummy, cross-over study comparing Chronocort and Plenadren.
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT05222152 | Chronocort Versus Plenadren Replacement Therapy in Adults With Adrenal Insufficiency | Derived from the trial | Yes |
Source ClinicalTrials.gov
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 41717588 | Corrigendum to "Effects of modified release hydrocortisone on restoration of early morning cortisol, quality of life, and fatigue in adrenal insufficiency (The CHAMPAIN study): a randomised, double-blind, double-dummy, cross-over study comparing Chronocort and Plenadren"[eClinical Medicine 91(2026); 103714]. | https://conductscience.org/library/papers/41717588 |
Source PubMed
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12788587 | Adrenal insufficiency. | Lancet | 2003 | https://conductscience.org/library/papers/12788587 | PubMed |
| 2 | 17684047 | Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis. | J Clin Endocrinol Metab | 2007 | https://conductscience.org/library/papers/17684047 | PubMed |
| 3 | 22090270 | Quality of life in European patients with Addison's disease: validity of the disease-specific questionnaire AddiQoL. | J Clin Endocrinol Metab | 2012 | https://conductscience.org/library/papers/22090270 | PubMed |
| 4 | 28223394 | Primary adrenal insufficiency is associated with impaired natural killer cell function: a potential link to increased mortality. | Eur J Endocrinol | 2017 | https://conductscience.org/library/papers/28223394 | PubMed |
| 5 | 29229498 | Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial. | Lancet Diabetes Endocrinol | 2018 | https://conductscience.org/library/papers/29229498 | PubMed |
| 6 | 38447948 | Salivary Cortisol Measurement Contamination After Oral Hydrocortisone: A Randomized Crossover Trial. | Horm Metab Res | 2024 | https://conductscience.org/library/papers/38447948 | PubMed |
| 7 | 38320034 | Home Waking Salivary Cortisone to Screen for Adrenal Insufficiency. | NEJM Evid | 2023 | https://conductscience.org/library/papers/38320034 | PubMed |
| 8 | 26124953 | Management of adrenocortical insufficiency with continuous subcutaneous hydrocortisone infusion: long-term experience in three patients. | Endocrinol Diabetes Metab Case Rep | 2015 | https://conductscience.org/library/papers/26124953 | PubMed |
| 9 | 33484633 | Adrenal insufficiency. | Lancet | 2021 | https://conductscience.org/library/papers/33484633 | PubMed |
| 10 | 23980724 | An oral multiparticulate, modified-release, hydrocortisone replacement therapy that provides physiological cortisol exposure. | Clin Endocrinol (Oxf) | 2014 | https://conductscience.org/library/papers/23980724 | PubMed |
| 11 | 23384710 | Increased use of antimicrobial agents and hospital admission for infections in patients with primary adrenal insufficiency: a cohort study. | Eur J Endocrinol | 2013 | https://conductscience.org/library/papers/23384710 | PubMed |
| 12 | 38571387 | Monitoring adrenal insufficiency through salivary steroids: a pilot study. | Eur J Endocrinol | 2024 | https://conductscience.org/library/papers/38571387 | PubMed |
| 13 | 26760044 | Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. | J Clin Endocrinol Metab | 2016 | https://conductscience.org/library/papers/26760044 | PubMed |
| 14 | 8468765 | Side effects of glucocorticoid treatment. Experience of the Optic Neuritis Treatment Trial. | JAMA | 1993 | https://conductscience.org/library/papers/8468765 | PubMed |
| 15 | 40576296 | Long-term outcomes in patients with congenital adrenal hyperplasia treated with hydrocortisone modified-release hard capsules. | Eur J Endocrinol | 2025 | https://conductscience.org/library/papers/40576296 | PubMed |
| 16 | 19223520 | Modified-release hydrocortisone to provide circadian cortisol profiles. | J Clin Endocrinol Metab | 2009 | https://conductscience.org/library/papers/19223520 | PubMed |
| 17 | 33574239 | GWAS for autoimmune Addison's disease identifies multiple risk loci and highlights AIRE in disease susceptibility. | Nat Commun | 2021 | https://conductscience.org/library/papers/33574239 | PubMed |
| 18 | 27387456 | Minimal important differences for fatigue patient reported outcome measures-a systematic review. | BMC Med Res Methodol | 2016 | https://conductscience.org/library/papers/27387456 | PubMed |
| 19 | 10487669 | Metabolic effects of short-term elevations of plasma cortisol are more pronounced in the evening than in the morning. | J Clin Endocrinol Metab | 1999 | https://conductscience.org/library/papers/10487669 | PubMed |
| 20 | 23543658 | Drug prescription patterns in patients with Addison's disease: a Swedish population-based cohort study. | J Clin Endocrinol Metab | 2013 | https://conductscience.org/library/papers/23543658 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42851403 | Health-related quality of life and patterns of psychological vulnerability in autoimmune Addison's disease: a systematic review. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42851403 | PubMed |
| 42761052 | A control theoretic primer for systems endocrinology. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42761052 | PubMed |
| 42652190 | Multidisciplinary Management of Pediatric Craniopharyngioma: From Diagnosis to Long-Term Outcomes. | Biomedicines | 2026 | https://conductscience.org/library/papers/42652190 | PubMed |
| 42050347 | Metabolic Effects of Modified-Release Hydrocortisone Versus Short Acting Conventional Oral Glucocorticoids in Adrenal Insufficiency: A Systematic Review and Meta-Analysis. | Clin Endocrinol (Oxf) | 2026 | https://conductscience.org/library/papers/42050347 | PubMed |
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| HYDROCORTISONE | CHEMBL389621 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL389621 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41552007
GET https://conductscience.org/api/papers/v1/41552007/references?page=2